Introduction and objectives: Papillary renal cell carcinoma (PRCC) accounts for 10-15% of renal tumors in adults. This type of tumor contains more than 75% of tubulo-papillary structures and is divided histologically into two subtypes. The distinction between these two subtypes is essential because of their prognostic value. The aim of this study was to compare the prognostic significance of the PRCC subtypes. Patients and methods: This retrospective study included 34 patients operated for PRCC between January 2000 and December 2012. Clinical data including presenting symptoms, preoperative findings, pathological features, treatment and patient outcome were taken from the patients' medical records as well as from radiological analysis based on computed tomography (CT) findings. A second analysis of the histological slides was made in doubtful cases to clarify the histological subtype. Results: PRCC was found in 12.7% of 267 patients operated for renal tumors during the study period. The patients' mean age was 62.4 years with a male predominance (sex ratio 3.6). All tumors were unilateral with a mean size of 6.9 cm. There was no clinical or radiological sign suggestive of this histological type, however, 80% of the tumors had an enhancement <40 HU. Treatment consisted of radical nephrectomy and nephron-sparing surgery in 74% and 26% of the cases, respectively. We found 20 type-1 tumors and 14 type-2 tumors. The 5-year overall and disease-free survival rates were 82% and 90% for type-1 and 42% and 54% for type-2 tumors, respectively. * Corresponding author. Conclusion: PRCC represents the second most common histological type of renal cancer. It has no clinical or radiological predicting signs, although CT enhancement is usually <40 HU. Distinguishing between the two subtypes is essential because of their prognostic value.
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Introduction
Papillary renal cell carcinoma (PRCC) accounts for 10-15% of renal tumors in adults. This type of tumor contains more than 75% of tubulo-papillary structures [1] . PRCC represents the second most common histological type after clear cell carcinoma (CCC). In 1997, Delahunt and Eble [2] described type-1 and type-2 subtypes of PRCC according to their cytological characteristics. This subdivision is important because of the prognostic value of each subtype [1] [2] [3] [4] [5] .
In the present study covering a period of 13 years, we reviewed 34 cases of PRCC operated between January 2000 and December 2012 and performed a long-term survival analysis comparing type-1 and type-2 PRCC to validate this subclassification as a prognostic factor.
Patients and methods
During the study period, 34/267 patients (12.7%) operated for renal cancer at our institution were diagnosed with PRCC. Data were obtained from the patients' medical records. The presenting symptoms, preoperative findings, pathological features, treatment and patient outcome were analyzed, and a comparative study of type-1 and type-2 PRCC was carried out.
The tumor stage was determined according to the 2009 TNM classification. A second analysis of the histological slides was made in doubtful cases to clarify the histological subtype. The tumor was classified as type-1 PRCC when it showed papillae covered with a single or double layer of small cuboid cells with basophilic cytoplasm (Fig. 1 ). Type-2 PRCC contains papillae covered with large eosinophilic cells arranged in a pseudo stratified manner (Fig. 2) . The statistical tests used were the Chi-square test to compare the qualitative variables and student's t-test for continuous variables, while the survival curves were derived from Kaplan-Meier estimates. A log-rank test was used to compare the survival rates of both groups. A p value <0.05 was considered as statistically significant. The statistical analysis was carried out using the SPSS 10.0 program.
Results
PRCC was found in 34/267 patients (12.7%) that underwent surgery for renal cancer. It represented the second most common histological type after CCC (75%). The patient cohort consisted of 25 men (74%) and 7 women (26%) with a sex ratio of 3.6. The patients' mean age was 62.4 (range 24-86) years.
The main risk factors were hypertension and diabetes mellitus, noted in 32% and 18%, respectively. Hemodialysis for end-stage renal disease was found in one case (3%).
The main presenting symptoms were flank pain (n = 22) and hematuria (n = 12). The tumor was discovered incidentally in 9 patients (27%). Most incidental cases were diagnosed after the second half of the study period (8% before 2005 and 44% after that year).
The tumors were located in the right kidney in 52% and in the left kidney in 48% of the patients. All tumors were unilateral, and multifocality was noted in one case (3%). The median tumor size was 6.9 cm (range 1.9-24) cm.
Computer tomography (CT) did not show any specificity regarding this histological type, however, enhancement was low (less than 40 HU) in 80% of the cases. Immediate complications occurred in 5 patients (18%): urinary fistula in one, pulmonary embolism in one and wound infection in 3 patients. Internal drainage by ureteral stenting was needed for the treatment of urinary fistula. Blood loss was negligible in all but two cases that needed blood transfusion. Nephron-sparing surgery was noted to be associated with a higher morbidity. The mean hospital stay was 5 (range 3-30) days.
Histological studies showed a tubulo-papillary aspect in 63% of the cases, while a pure papillary aspect was seen in 37%. The presence of sarcomatoid cells was noted in one case.
We found 20 cases of type-1 (59%) and 14 cases of type-2 PRCC (41%). Immunohistochemical study was necessary in one case to confirm the histologic diagnosis. It showed cells positive for cytokeratin 7.
The median follow-up after surgery was 42 (range 6-100) months. The 5-year overall survival and disease-free survival rates were 73.3% and 92%, respectively. Recurrence occurred in 3 cases two years after surgery; none of them had had partial nephrectomy as initial treatment.
The tumor characteristics according to the pathologic subtype are summarized in Table 1 . Type-2 tumors were associated with a more advanced TNM stage, a high Fuhrman grade (grades 3 and 4) and a worse prognosis. The overall and disease-free survival rates were 82% and 90% for patients with type-1 tumors and 42% and 54% for those with type-2 tumors, respectively. The Kaplan-Meier overall survival is presented in Fig. 3 .
Discussion
PRCC derives from cells of the distal tubule of the nephron [1] . This type of tumor represents the second most common histological type of renal cancer after CCC, accounting for 10-5% of the cases. It is usually diagnosed between the age of 50 and 60 [6] and occurs more frequently in men with a sex ratio of 1.6-5.
Figure 3
The Kaplan-Meier overall survival curves according to tumor subtype.
The most common risk factors for renal cancer are hypertension, diabetes mellitus, obesity and smoking [7, 8] . End-stage renal failure is a well-known risk factor of PRCC [9, 10] , but this was not found in our study. The male predominance (3/4 of our patients with PRCC) noted in this study confirms the results of previous studies [1] .
According to the literature, renal cancer is diagnosed incidentally in 60-70% of cases [7] ; however in our study, incidental diagnosis was not common (29%) because we lack ultrasonography in rural hospitals.
Multifocality is another known feature of PRCC, with a reported incidence of 20% to 41% [2] , however, this high percentage is usually found in hereditary cases [11] . Cytogenetic studies suggest that many mutations in different locations of the same kidney explain multifocality in hereditary PRCC [12] . In sporadic cases, multifocality of PRCC has been reported to account for around 7% [1, 5] . In our study, we did not find any association between multifocality and PRCC as all cases were sporadic.
CT scan is the gold standard for exploring renal tumors. PRCC is usually more homogenous than CCC, especially in tumors <3 cm with less enhancement [13, 14] . These findings are usually correlated to low-stage tumors [4] . There are no radiological signs that can distinguish between the two PRCC subtypes. In this study we found that 80% of the tumors had an enhancement < 40 HU.
The histological pattern shows that PRCC is characterized by a predominance (more than 50-70%) of papillary or tubulo-papillary structures in the absence of clear cells [9] . In doubtful cases we can use immunohistochemical studies to search for a positive reaction to cytokeratin 7. Delahunt and Eble [2] were the first to describe the existence of two PRCC subtypes. This subclassification was added to the WHO classification of 2004 [15] . Tumors are classified as type-1 PRCC when they show papillae covered with small cuboid cells with basophilic cytoplasm, whereas type-2 tumors contain papillae covered with large eosinophilic cells. The latter are usually associated with a high TNM grade and a worse prognosis. This prognostic value was confirmed by other studies, where a disease-free survival rate of 92% was reported for type-1 compared to 44% for type-2 PRCC tumors [1, 16] .
Conclusions
PRCC represents the second most common histological type of renal cancer. It has no clinical or radiological predicting signs, although CT enhancement is usually less than 40 HU. Distinguishing between its two subtypes is essential because of their prognostic value.
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